-
Product Insights
NewPeptidyl Prolyl Cis-Trans Isomerase F Mitochondrial – Drugs In Development, 2024
The Peptidyl Prolyl Cis-Trans Isomerase F Mitochondrial pipeline drugs market research report outlays comprehensive information on the Peptidyl Prolyl Cis-Trans Isomerase F Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Gastrointestinal, Metabolic Disorders, and Genito Urinary System which include indications of Epilepsy, Parkinson's Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Obesity, Subacute Necrotizing...
-
Product Insights
NewFKBP Type Peptidyl-Prolyl Cis-Trans Isomerase – Drugs In Development, 2024
The FKBP Type Peptidyl-Prolyl Cis-Trans Isomerase pipeline drugs market research report outlays comprehensive information on the FKBP Type Peptidyl-Prolyl Cis-Trans Isomerase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Immunology, and Genito Urinary System which include indications of Parkinson's Disease, Amyotrophic Lateral Sclerosis, Squamous Cell Carcinoma, Kidney Transplant Rejection, Liver Transplant Rejection, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Plerixafor + Tacrolimus) in Wounds
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Plerixafor + Tacrolimus) in Wounds report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Plerixafor + Tacrolimus) in Wounds Drug Details: MRG-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICIP in Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICIP in Skin Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Skin Cancer Drug Details: iCIP is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICIP in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICIP in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Solid Tumor Drug Details: iCIP is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Isuzinaxib in Acute Renal Failure (ARF) (Acute Kidney Injury)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Isuzinaxib in Acute Renal Failure (ARF) (Acute Kidney Injury) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Isuzinaxib in Acute Renal Failure (ARF)...
-
Product Insights
NewCochlear Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cochlear Implants Pipeline Market Report Overview A cochlear implant (CI) bionic ear is a device that can be surgically implanted into a person's cochlea to stimulate it to enhance or restore hearing. The cochlear implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nogapendekin Alfa in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nogapendekin Alfa in Hypopharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nogapendekin Alfa in Hypopharyngeal Cancer Drug Details: Nogapendekin alfa (Anktiva)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nogapendekin Alfa in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nogapendekin Alfa in Laryngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nogapendekin Alfa in Laryngeal Cancer Drug Details: Nogapendekin alfa (Anktiva)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nogapendekin Alfa in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nogapendekin Alfa in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nogapendekin Alfa in Oropharyngeal Cancer Drug Details: Nogapendekin alfa (Anktiva)...